Femasys Inc.
FEMYNASDAQHealthcare● Active
$5.39
$-0.74(-12.04%)
Market Cap$18966116
P/E Ratio—
52W High$22.2
52W Low$5.09
Femasys Inc. (FEMY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
FEMY · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 8, 2026EPS Actual
$0.10
Est. -$0.07 · +247.0%
Revenue
$0.00B
Est. $0.00B · -44.6%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 8, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue🔥 4-Quarter EPS Beat Streak
FEMY reports quarterly as a NASDAQ-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$1.62
Rev. $1.20B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$1.62
Rev. Est.$1.20B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | -$0.06 | — | — | — | $0.00B | — |
| ▲ Q2 FY2026 | May 8, 2026 | -$0.07 | $0.10 | +247.0% | $0.00B | $0.00B | -44.6% |
| ▲ Q1 FY2026 | Mar 31, 2026 | -$0.08 | -$0.01 | +88.0% | $0.00B | $0.00B | -23.2% |
| ▲ Q4 FY2025 | Nov 14, 2025 | -$0.12 | -$0.10 | +13.0% | $0.00B | $0.00B | -46.0% |
| ▲ Q3 FY2025 | Aug 8, 2025 | -$0.18 | -$0.16 | +11.1% | $0.00B | $0.00B | -60.1% |
| ▼ Q2 FY2025 | May 8, 2025 | -$0.17 | -$0.23 | -35.3% | $0.00B | $0.00B | -70.1% |
| ▼ Q1 FY2025 | Mar 27, 2025 | -$0.18 | -$0.23 | -24.3% | $0.00B | $0.00B | -65.0% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -$0.20 | -$0.24 | -20.0% | $0.00B | $0.00B | -18.1% |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
-$0.06
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 8, 2026Beat
EPS Actual
$0.10
EPS Est.
-$0.07
EPS Surpr.
+247.0%
Revenue
$0.00B
Q1 FY2026
Mar 31, 2026Beat
EPS Actual
-$0.01
EPS Est.
-$0.08
EPS Surpr.
+88.0%
Revenue
$0.00B
Q4 FY2025
Nov 14, 2025Beat
EPS Actual
-$0.10
EPS Est.
-$0.12
EPS Surpr.
+13.0%
Revenue
$0.00B
Q3 FY2025
Aug 8, 2025Beat
EPS Actual
-$0.16
EPS Est.
-$0.18
EPS Surpr.
+11.1%
Revenue
$0.00B
Q2 FY2025
May 8, 2025Miss
EPS Actual
-$0.23
EPS Est.
-$0.17
EPS Surpr.
-35.3%
Revenue
$0.00B
Q1 FY2025
Mar 27, 2025Miss
EPS Actual
-$0.23
EPS Est.
-$0.18
EPS Surpr.
-24.3%
Revenue
$0.00B
Q4 FY2024
Nov 12, 2024Miss
EPS Actual
-$0.24
EPS Est.
-$0.20
EPS Surpr.
-20.0%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.00 | $0.00 | $0.00 | 1 |
| Q3 FY2028 | $0.00 | $0.00 | $0.00 | 1 |
| Q2 FY2028 | $0.00 | $0.00 | $0.00 | 1 |
| Q1 FY2028 | $0.00 | $0.00 | $0.00 | 1 |
| Q4 FY2027 | $-0.09 | $-0.07 | $-0.05 | 1 |
| Q3 FY2027 | $-0.09 | $-0.07 | $-0.05 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 8, 2026 | +247.0% | $8.98 | $8.60 | -4.23% |
| ▲ Q1 FY2026 | Mar 31, 2026 | +88.0% | $7.52 | $8.40 | +11.70% |
| ▲ Q4 FY2025 | Nov 14, 2025 | +13.0% | $16.53 | $17.95 | +8.59% |
| ▲ Q3 FY2025 | Aug 8, 2025 | +11.1% | $17.65 | $17.86 | +1.19% |
| ▼ Q2 FY2025 | May 8, 2025 | -35.3% | $22.80 | $23.00 | +0.88% |
| ▼ Q1 FY2025 | Mar 27, 2025 | -24.3% | $30.40 | $26.80 | -11.84% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -20.0% | $23.40 | $20.60 | -11.97% |
| ▼ Q3 FY2024 | Aug 8, 2024 | -16.7% | $21.00 | $17.20 | -18.10% |
Q2 FY2026-4.23%
Report Date
May 8, 2026
EPS Beat/Miss
+247.0%
Price Before
$8.98
Price After
$8.60
Q1 FY2026+11.70%
Report Date
Mar 31, 2026
EPS Beat/Miss
+88.0%
Price Before
$7.52
Price After
$8.40
Q4 FY2025+8.59%
Report Date
Nov 14, 2025
EPS Beat/Miss
+13.0%
Price Before
$16.53
Price After
$17.95
Q3 FY2025+1.19%
Report Date
Aug 8, 2025
EPS Beat/Miss
+11.1%
Price Before
$17.65
Price After
$17.86
Q2 FY2025+0.88%
Report Date
May 8, 2025
EPS Beat/Miss
-35.3%
Price Before
$22.80
Price After
$23.00
Q1 FY2025-11.84%
Report Date
Mar 27, 2025
EPS Beat/Miss
-24.3%
Price Before
$30.40
Price After
$26.80
Q4 FY2024-11.97%
Report Date
Nov 12, 2024
EPS Beat/Miss
-20.0%
Price Before
$23.40
Price After
$20.60
Q3 FY2024-18.10%
Report Date
Aug 8, 2024
EPS Beat/Miss
-16.7%
Price Before
$21.00
Price After
$17.20
Avg Beat Reaction+4.31%
Avg Miss Reaction-10.26%
Beat Rate4 / 8 quarters
Largest Move-18.10% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: FEMY ends December
Femasys Inc. (FEMY) most recently reported earnings on May 8, 2026 for Q2 FY2026, posting EPS of $0.10 — beating the analyst consensus of $-0.07 by +247.0%. FEMY has beaten EPS estimates for 4 consecutive quarters. The next FEMY earnings date is expected around September 1, 2026.
Each quarter, investors track FEMY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. FEMY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
FEMY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
FEMY earnings · 5 questionsFemasys Inc.'s next earnings report is expected around September 1, 2026. FEMY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; FEMY historically reports after market close (AMC).
FEMY earnings datewhen is FEMY earningsFEMY next earnings datewhen does FEMY report earningsFEMY earnings calendar
▸ Source: FMP · Femasys Inc. SEC filings · US GAAP · Femasys Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026